Childhood-onset systemic lupus erythematosus;Le lupus érythémateux disséminé de l'enfant

Archives de Pediatrie

Volumn 10, Issue 2, 2003, Pages 147-157

  Bader Meunier, B ^a   Quartier, P ^b   Deschenes G ^c   Cochat, P ^d   Haddad, E ^e   Kone Paut I ^f   Leblanc, T ^g   Prieur, A M ^b   Salomon, R ^b   Bodemer, C ^b   Levy M ^a  

^a BICÊTRE HOSPITAL   (France)

^b HÔPITAL NECKER ENFANTS MALADES   (France)

^c Serv de Pneumologie Pediat   (France)

^d EDOUARD HERRIOT HOSPITAL   (France)

^e HÔPITAL ROBERT DEBRÉ   (France)

^f HÔPITAL NORD   (France)

^g SAINT LOUIS HOSPITAL   (France)

Author keywords

Child; Clinical protocols; Diagnostic techniques and procedures; Lupus erythematosus systemic

Indexed keywords

ACETYLSALICYLIC ACID; ANTINUCLEAR ANTIBODY; AZATHIOPRINE; CD40 LIGAND MONOCLONAL ANTIBODY; COMPLEMENT; CYCLOPHOSPHAMIDE; CYCLOSPORIN; HYDROXYCHLOROQUINE; IMMUNOGLOBULIN; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NONSTEROID ANTIINFLAMMATORY AGENT; PHOSPHOLIPID ANTIBODY; PREDNISOLONE;

ANTIPHOSPHOLIPID SYNDROME; AUTOIMMUNITY; CHILD; CLINICAL FEATURE; CORTICOSTEROID THERAPY; HEREDITY; HUMAN; MORBIDITY; ONSET AGE; PATHOGENESIS; REVIEW; SYSTEMIC LUPUS ERYTHEMATOSUS; VACCINIA;

EID: 0344059155     PISSN: 0929693X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0929-693X(03)00313-0     Document Type: Short Survey

References (78)

1. Tucker LB, Menon S, Schaller JG, Isenberg DA. Adult and childhood-onset systemic lupus erythematosus: a comparison of onset, clinical features, serology and outcome. Br J Rheumatol 1995;34:866-72.
2. Font J, Cervera R, Espinosa G, Pallares L, Ramos-Casals M, Jimenez S, et al. Systemic Lupus Erythematosus (SLE) in childhood: analysis of clinical and immunological findings in 34 patients and comparison with SLE characteristics in adults. Ann Rheum Dis 1998;57:456-9.
3. Rood MJ, ten Cate R, Van Suijlekom-Smit LWA, den Ouden EJ, Ouwerkerk FE, Breedveld FC, et al. Childhood-onset systemic lupus erythematosus. Scand J Rheumatol 1999;28:222-6.
4. Iqbal S, Sher MR, Good RA, Cawkwell GD. Diversity in presenting manifestations of systemic lupus erythematosus in children. J Pediatr 1999;135:500-5.
5. Carreno L, Lopez-Longo FJ, Monteagudo I, Rodriguez-Mahou M, Bascones M, Gonzalez CM, et al. Immunological and clinical differences between juvenile and adult onset of systemic lupus erythematosus. Lupus 1999;8:287-92.
6. Barron KS, Silverman ED, Gonzales J, Reveille JD. Clinical, serologic and immunogenetic studies in childhood-onset systemic lupus erythematosus. Arthritis Rheum 1993;36:348-52.
7. Costallat LTL, Coimbra AMV. Systemic lupus erythematosus: clinical and laboratory aspects related to age at disease onset. Clin Exp Rheumatol 1994;12:603-7.
8. Niaudet P. Traitement de la néphropathie du lupus érythémateux disséminé de l'enfant. Arch Pediatr 1999;6:1312-21.
9. Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, et al. The 1982 revisited criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982;25:1271-7.
10. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997;40:1725.
11. Smith EL, Shmerling RH. The American college of rheumatology criteria for the classification of systemic lupus erythematosus: strengths, weakness and opportunities for improvement. Lupus 1999;8:586-95.
12. Van de Brink H, Smeenk RJT, Manger K, Kalden JR, Tosi S, Marchesoni A, et al. Incomplete lupus erythematosus: results of a multicentre study under the supervision of the EULAR standing committee on international clinical studies including therapeutics trials. Rheumatology 2001;40:89-94.
13. Ferraz MB, Goldenberg J, Hilario MO, Bastos WA, Oliveira SK, Azevedo ECL. Evaluation of the 1982 ARA lupus criteria data set in pediatric patients. Clin Exp Rhumatol 1994;12:83-7.
14. Lévy M, Montes de Oca M, Babron MC. Incidence du lupus érythémateux disséminé de l'enfant en région parisienne. Presse Méd 1989;18:2022.
15. Lawrence JS, Martins CL, Drake GL. A family survey of lupus erythematosus, 1. Heritability. J Rheumatol 1987;14:913-21.
16. Deapen D, Escalante A, Weinrib L, Horwitz D, Bachman B, Roy-Burman P, et al. A revised estimate of twin concordance in systemic lupus erythematosus. Arthritis Rheum 1992;35:311-8.
17. Pickering MC, Botto M, Taylor PR, Lachmann PJ, Walport MJ. Systemic lupus erythematosus, complement deficiency and apoptosis. Adv Immunol 2000;76:227-324.
18. Walport MJ. Complement, First of two parts. N Engl J Med 2001;344:1058-66.
19. Vyse TJ, Kotzin BL. Genetic basis of systemic lupus erythematosus. Curr Opin Immunol 1996;8:843-51.
20. Davies EJ, Snowden N, Hillarby MC, Carthy D, Grennan DM, Thomson W, et al. Mannose-binding protein gene polymorphism in systemic lupus erythematosus. Arthritis Rheum 1995;38:110-4.
21. Gaffney PM, Ortmann WA, Selby SA, Shark KB, Ockenden TC, Rohlf KE, et al. Genome screening in human systemic lupus erythematosus: results from a second Minnesota cohort and combined analyses of 187 sib-pair families. Am J Hum Genet 2000;66:547-56.
22. Moser KL, Neas BR, Salmon JE, Yu H, Gray-McGuire C, Asundi N, et al. Genome scan of human systemic lupus erythematosus: evidence for linkage on chromosome 1q in African-American pedigrees. Proc Natl Acad Sci USA 1998;95:14 869-74.
23. Shai R, Quismorio FP, Li L, Kwon OJ, Morrison J, Wallace DJ, et al. Genome-wide screen for systemic lupus erythematosus susceptibility genes in multiplex families. Hum Mol Genet 1999;8:639-44.
24. Lindqvist AK, Steinsson K, Johanneson B, Kristjansdottir H, Arnasson A, Grondal G, et al. A susceptibility locus for human Systemic Lupus Erythematosus (hSLE1) on chromosome 2q. J Autoimmun 2000;14:169-78.
25. Hugot JP, Chamaillard M, Zouali H, Lesage S, Cezard JP, Belaiche J. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature 2001;411:599-603.
26. Botto M, Dell'Agnola C, Bygrave AE, Thompson EM, Cook HT, Petry F, et al. Homozygous C1q deficiency causes glomerulonephritis associated with multiple apoptotic bodies. Nat Genet 1998;19:56-9.
27. Mitchell DA, Pickering MC, Warren J, Fossati-Jimack L, Cortes-Hernandez J, Cook HT, et al. C1q deficiency and autoimmunity: the effects of genetic background on disease expression. J Immunol 2002;68:2538-43.
28. Wakeland EK, Liu K, Graham RR, Behrens TW. Delineating the genetic basis of systemic lupus erythematosus. Immunity 2001;15:397-408.
29. Robson MG, Walport MJ. Pathogenesis of Systemic Lupus Erythematosus (SLE). Clin Exp Allergy 2001;31:678-85.
30. Balomenos D, Martin-Caballero J, Garcia MI, Prieto I, Flores JM, Serrano M, et al. The cell cycle inhibitor p21 controls T-cell proliferation and sex-linked lupus development. Nat Med 2000;6:171-6.
31. Casciola-Rosen LA, Anhalt G, Rosen A. Autoantigens targeted in systemic lupus erythematosus are clustered in two populations of surface structures on apoptotic keratinocytes. J Exp Med 1994;179:1317-30.
32. James JA, Kaufman KM, Farris AD, Taylor-Albert E, Lehman TJ, Harley JB. An increased prevalence of Epstein-Barr virus infection in young patients suggests a possible etiology for systemic lupus erythematosus. J Clin Invest 1997;100:3019-26.
33. Wananukul S, Watana D, Pongprasit P. Cutaneous manifestations of childhood systemic lupus erythematosus. Pediatr Dermatol 1998;15:342-6.
34. Mont MA, Glueck CJ, Pacheco IH, Wang P, Hungerford DS, Petri M. Risk factors for osteonecrosis in systemic lupus erythematosus. J Rheumatol 1997;24:654-62.
35. Parikh S, Swaiman KF, Kim Y. Neurologic characteristics of childhood lupus erythematosus. Pediatr Neurol 1995;13:198-201.
36. Uziel Y, Laxer RM, Blaser S, Andrew M, Schneider R, Silverman ED. Cerebral vein thrombosis in childhood systemic lupus erythematosus. J Pediatr 1995;126:722-7.
37. Chaves-Carballo E, Dabbagh O, Bahabri S. Pseudotumor cerebri and leukoencephalopathy in childhood lupus. Lupus 1998;8:81-4.
38. Delgado EA, Malleson PN, Pirie GE, Petty RE. The pulmonary manifestations of childhood onset systemic lupus erythematosus. Seminars Arthr Rheum 1990;19:285-93.
39. Trapani S, Camiciottoli G, Ermini M, Castellani W, Falcini F. Pulmonary involvement in juvenile systemic lupus erythematosus: a study on lung function in patients asymptomatic for respiratory disease. Lupus 1999;7:545-50.
40. Guevara JP, Clark BJ, Athreya BH. Point prevalence of cardiac abnormalities in children with systemic lupus erythematosus. J Rheumatol 2001;28:854-9.
41. Gazarian M, Feldman BM, Benson LN, Gilday DL. Laxer RM, Silverman ED. Assessment of myocardial perfusion and function in childhood systemic lupus erythematosus. J Pediatr 1998;132:109-16.
42. Zimmerman SA, Ware RE. Clinical significance of the antinuclear antibody test in selected children with idiopathic thrombocytopenic purpura. J Pediatr Hematol Oncol 1997;19:297-303.
43. Seaman DE, Londino AV, Kwoh CK, Medsger TA, Manzi S. Antiphospholipid antibodies in pediatric systemic lupus erythematosus. Pediatrics 1995;96:1040-5.
44. Brunner HI, Freedman M, Silverman ED. Close relationship between systemic lupus erythematosus and thrombotic thrombocytopenic purpura in childhood. Arthrirtis Rheum 1999;42:2346-55.
45. Song KS, Park YS, Kim HK. Prevalence of anti-proteine-S antibodies in patients with systemic lupus erythematosus. Arthritis Rheum 2000;43:557-60.
46. Male C, Mitchell L, Julian J, Vegh P, Joshua P, Adams M, et al. Acquired activated protein C resistance is associated with lupus anticoagulants and thrombotic events in pediatric patients with systemic lupus erythematosus. Blood 2001;97:844-9.
47. Berube C, Mitchell L, Silverman E, David M, Saint Cyr C, Laxer R, et al. The relationship of antiphospholipid antibodies to thromboembolic events in pediatric patients with systemic lupus erythematosus: a cross-sectional study. Pediatr Res 1998;44:351-6.
48. Montes de Oca MA, Babron MC, Blétry O, Broyer M, Courtecuisse V, Fontaine JL, et al. Thrombosis in systemic lupus erythematosus: a French collaborative study. Arch Dis Child 1991;66:713-7.
49. Voss A, Jacobsen S, Heegaard NNH. Association of β2-glycoprotein IgG and IgM antibodies with thrombosis and thrombocytopenia. Lupus 2001;1(10):533-8.
50. Wilson WA, Gharavi AE, Koike K, Lockshin MD, Branch DW, Pierre JC, et al. International consensus statement on preliminary classsification criteria for definite antiphospholipid syndrome. Arthr Rheum 1999;42:1309-11.
51. Baudoin V, Bocquet N, Macher MA, Peuchmaur M, Loirat C. Néphropathie lupique de l'enfant. In: Médecine-Science Flammarion éd, editor. Journées Parisiennes de Pédiatrie. 1997. p. 285-93.
52. Gloor JM. Lupus nephritis in children. Lupus 1998;7:639-43.
53. Yang LY, Chen WP, Lin CY. Lupus nephritis in children-A review of 167 patients. Pediatrics 1994;94:335-40.
54. Sandborg CI. Childhood systemic lupus erythematosus and neonatal lupus syndrome. Current Opinion Rheumatol 1998;10:481-7.
55. Ravelli A, Caria MC, Malattia C, Temporini F, Cavallero A, et al. Uncommon causes of liver disease in juvenile systemic lupus erythematosus. Clin Exp Rheum 2001;19:474.
56. Eberhard BA, Laxer RM, Eddy AA, Silverman ED. Presence of thyroid abnormalities in children with systemic lupus erythematosus. J Pediatr 1991;119:277-9.
57. Malleson PN, Sailer M, Mackinnon MJ. Usefulness of antinuclear antibody testing to screen for rheumatic diseases. Arch Dis Child 1997;77:299-304.
58. Silverman ED, Laxer RM. Neonatal lupus erythematosus. Rheum Dis North Am 1997;23:599-618.
59. Neiman AR, Lee LA, Weston WL, Buyon JP. Cutaneous manifestations of neonatal lupus without heart block: characteristics of mothers and children enrolled in a national registry. J Pediatr 2000;137:674-80.
60. Lee LA, Sokol RJ, Buyon JP. Hepatobiliary disease in neonatal lupus: prevalence and clinical characteristics in cases enrolled in a national registry. Pediatrics 2002;109:E11.
61. Cabanas F, Pellicier A, Valverde E, Morales C, Quero J. Central nervous system vasculopathy in neonatal lupus erythematosus. Pediatr Neurol 1996;15:124-6.
62. Shakoor N, Michalska M, Harris CA, Block JA. Drud-induced systemic lupus erythematosus associated with etanercept therapy. Lancet 2002;359:579-80.
63. The Canadian Hydroxychloroquine Study Group. A randomized study of the effect of withdrawing hydrochloroquine sulfate in systemic lupus erythematosus. N Engl J Med 1991;324:150-5.
64. Wang C, Fortin PR, Li Y, Panaritis T, Gans M, Esdaile JM, et al. Discontinuation of antimalarial drugs in systemic lupus erythematosus. J Rheumatol 1999;26:808-15.
65. Lehman TJA. Modern treatment of childhood SLE. Clin Exp Rheumatol 2001;19:487-9.
66. Abud-Mendoza C, Sturbaum AK, Vazquez-Compean R, Gonzalez-Amaro R. Methotrexate therapy in childhood systemic lupus erythematosus. J Rheumatol 1993;20:731-3.
67. Ravelli A, Ballardini G, Viola S, Villa I, Ruperto N, Martini A. Methotrexate therapy in refractory systemic lupus erythematosus. J Rheumatol 1998;25:572-5.
68. Feutren G, Querin S, Noël LH, Chatenoud L, Beaurain G, Tron F, et al. Effects of cyclosporine in severe systemic lupus erythematosus. J Pediatr 1987;111:1063-8.
69. Ruiz-Irastorza G, Khamashta MA, Castellino G, Hughes GRV. Systemic lupus erythematosus. Lancet 2001;357:1027-32.
70. Buratti S, Szer IS, Spencer CH, Bartosh S, Reiff A. Mycophenolate Mofetil treatment of severe renal disease in pediatric onset systemic lupus erythematosus. J Rheum 2001;28:2103-8.
71. Wulffraat NM, Sanders EAM, Kamphuis SSM, Rijkers GT, Kuis W, Lilien M. Prolonged remission without treatment after autologous stem cell transplantation for refractory childhood systemic lupus erythematosus. Arthritis Rheum 2001;44:728-34.
72. Perrota S, Locatelli F, La Manna A, Cennamo L, De Stefano P, Nobili B. Anti-CD20 monoclonal antibody (Rituximab) for life threatening autoimmune haemolytic anaemia in a patient with systemic lupus erythematosus. Br J Haematol 2002;116:465-7.
73. Aron-Maor, Shoenfeld Y. Vaccination and systemic lupus erythematosus: the bidirectional dilemmas. Lupus 2001;10:237-40.
74. Barr SG, Zonana-Nacach A, Madger LS, Petri M. Patterns of disease activity in systemic lupus erythematosus. Arthritis Rheum 1999;42:2682-8.
75. Brunner HI, Silverman ED, To T, Bombardier C, Feldman BM. Risk factors for damage in childhood-onset systemic lupus erythematosus. Arthritis Rheum 2002;46:436-44.
76. Lacks S, White P. Morbidity associated with childhood systemic lupus erythematosus. J Rheumatol 1990;17:941-5.
77. Lévy M, Montes de Oca MA, Babron MC. Unfavorable outcomes (end-stage renal failure/death) in childhood onset systemic lupus erythematosus, A multicenter study in Paris and its environs. Clin Exp Rheumatol 1994 Sep-Oct;12(Suppl 10):S63-8.
78. Urowitz MB, Gladman DD. Accelerated atheroma in lupus-background. Lupus 2000;9:161-5.